MedTrace Logo

A Multicenter, Prospective, oBservational Study to assEss the Clinical activitY and Impact on symptOm Burden and patieNts' HRQoL of Treatment With trabecteDin in aSTS in a Real World Setting in Greece

NCT02618122 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 63

Last updated 2020-11-30

No results posted yet for this study

Summary

This non-interventional study aims primarily at assessing the clinical effectiveness and the impact of the therapy on cancer-related symptoms and patients' HRQoL. In addition, it represents an attempt towards gaining experience on the routine use of trabectedin in daily clinical practice in a representative sample of Greek subjects with aSTS.

Conditions

  • Advanced Soft Tissue Sarcoma

Sponsors & Collaborators

  • Genesis Pharma S.A.

    lead INDUSTRY

Principal Investigators

  • Kiki Karvounis · GenesisPharma Medical Department

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2019-06-30
Completion
2019-08-06

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02618122 on ClinicalTrials.gov